A Phase II , Placebo-controlled Study to Assess Efficacy of 28 Day Oral AZD9668 in Patients With Bronchiectasis

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions

Bronchiectasis

Interventions

DRUG

AZD9668

2 x 30 mg, oral tablet, twice daily for 28 days

DRUG

Placebo

2 x Matched placebo, oral tablet, twice daily for 28 days

Trial Locations (9)

Research Site, Chemin Sainte-Foy

Research Site, Calgary

Research Site, Montreal

Research Site, Ontario

Research Site, Vancouver

Research Site, Birmingham

Research Site, Cambridge

Research Site, London

Research Site, Newcastle